LYTE THEIR WAY
Live / Applied — Fifth extension granted (statement of use) (as of 14 Oct 2025)
What this means for you
Not registered yet, but its 29 Apr 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97388283
- Mark type
- Stylized text
- Filed
- 29 Apr 2022
- Published for opposition
- 28 Mar 2023
- Attorney of record
- Danielle Rivera
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations for the treatment of central nervous system diseases and disorders; Pharmaceutical preparations for the treatment of schizophrenia; Pharmaceutical preparations for the treatment of bipolar disorder
Owner
- INTRA-CELLULAR THERAPIES, INC., Bedminster, NJ, US
- INTRA-CELLULAR THERAPIES, INC., New York, NY, US
Prosecution history
- 15 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Oct 2025 — SOU EXTENSION 5 GRANTED
- 12 Oct 2025 — SOU EXTENSION 5 FILED
- 13 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 12 Aug 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 12 Aug 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 12 Aug 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 12 Aug 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 12 Aug 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 24 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 May 2025 — SOU EXTENSION 4 GRANTED
- 23 May 2025 — SOU EXTENSION 4 FILED
- 23 May 2025 — SOU TEAS EXTENSION RECEIVED
- 13 Jun 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 May 2024 — SOU EXTENSION 3 GRANTED